ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in ADC Therapeutics SA as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +11 vs. Q1 2022
- Shares held
- 34.5M
- +1.90M (+5.8%) vs. Q1 2022
- Total value
- $274.1M
- −$204.5M (−42.7%) vs. Q1 2022
- New holders
- 15
- 15 more added
- Sold out
- 4
- 9 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $86.3M |
| Q1 2026 | 118 | $312.9M |
| Q4 2025 | 115 | $292.8M |
| Q3 2025 | 106 | $271.3M |
| Q2 2025 | 86 | $182.1M |
| Q1 2025 | 82 | $77.3M |
| Q4 2024 | 83 | $112.4M |
| Q3 2024 | 77 | $172.9M |
| Q2 2024 | 74 | $163.7M |
| Q1 2024 | 37 | $155.8M |
| Q4 2023 | 38 | $56.4M |
| Q3 2023 | 41 | $35.4M |
| Q2 2023 | 56 | $97.5M |
| Q1 2023 | 59 | $90.9M |
| Q4 2022 | 60 | $149.1M |
| Q3 2022 | 66 | $176.5M |
| Q2 2022 | 58 | $274.1M |
| Q1 2022 | 49 | $501.3M |
| Q4 2021 | 55 | $682.8M |
| Q3 2021 | 53 | $890.6M |
| Q2 2021 | 56 | $816.3M |
| Q1 2021 | 59 | $801.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding ADC Therapeutics SA; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Salem Investment Counselors Inc | 35 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 33 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Venture Visionary Partners LLC | 100 | $795 | 0.00% | +100 | New |
| First Manhattan Co | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 300 | $2.00K | 0.00% | −50−14.3% | Reduced |
| Focused Wealth Management, Inc | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 200 | $2.00K | 0.00% | 00.0% | Unchanged |
| Assetmark, Inc | 365 | $3.00K | 0.00% | +200+121.2% | Added |
| Tower Research Capital LLC (TRC) | 700 | $6.00K | 0.00% | −37−5.0% | Reduced |
| Banque Cantonale Vaudoise | 1,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Sterling Investment Advisors, Ltd. | 1,100 | $9.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,491 | $12.0K | 0.00% | +600+67.3% | Added |
| Quantbot Technologies LP | 4,852 | $38.0K | 0.00% | +4,852 | New |
| Advisor Group Holdings, Inc. | 5,483 | $44.0K | 0.00% | +2,235+68.8% | Added |
| Bank of America Corp | 6,342 | $50.0K | 0.00% | −1,267−16.7% | Reduced |
| Cypress Capital Group | 10,000 | $80.0K | 0.01% | +10,000 | New |
| Squarepoint Ops LLC | 11,014 | $88.0K | 0.00% | +11,014 | New |
| Graham Capital Management, L.P. | 12,992 | $103.0K | 0.00% | +12,992 | New |
| State Street Corp | 14,028 | $112.0K | 0.00% | +14,028 | New |
| Cna Financial Corp | 15,515 | $123.0K | 0.04% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 16,098 | $127.0K | 0.00% | +16,098 | New |
| Moneta Group Investment Advisors LLC | 19,497 | $155.0K | 0.01% | +28+0.1% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 21,408 | $170.0K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 25,060 | $198.0K | 0.00% | +89+0.4% | Added |
| Woodline Partners LP | 33,841 | $269.0K | 0.00% | +33,841 | New |
| Hennion & Walsh Asset Management, Inc. | 38,700 | $308.0K | 0.02% | +38,700 | New |
| Alps Advisors Inc | 45,563 | $362.0K | 0.00% | −33,282−42.2% | Reduced |
| Millennium Management LLC | 57,965 | $461.0K | 0.00% | +57,965 | New |
| Endurant Capital Management LP | 58,967 | $469.0K | 0.18% | +58,967 | New |
| Allianz Asset Management GmbH | 61,760 | $491.0K | 0.00% | −6,050−8.9% | Reduced |
| Manufacturers Life Insurance Company, The | 77,745 | $605.6K | 0.00% | +13,343+20.7% | Added |
| Renaissance Technologies LLC | 79,900 | $635.0K | 0.00% | +79,900 | New |
| Ameriprise Financial Inc | 79,976 | $636.0K | 0.00% | +4,946+6.6% | Added |
| Balyasny Asset Management LLC | 86,100 | $684.0K | 0.00% | +86,100 | New |
| TD Asset Management Inc | 92,290 | $734.0K | 0.00% | 00.0% | Unchanged |
| Indie Asset Partners, LLC | 93,989 | $747.0K | 0.66% | −2,583−2.7% | Reduced |
| ExodusPoint Capital Management, LP | 139,192 | $1.11M | 0.02% | +139,192 | New |
| Magnetar Financial LLC | 167,698 | $1.33M | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 205,568 | $1.63M | 0.00% | +119,703+139.4% | Added |
| Employees Retirement System of Texas | 312,000 | $2.48M | 0.04% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 334,384 | $2.66M | 0.74% | 00.0% | Unchanged |
| Matrix Capital Management Company, LP | 400,000 | $3.18M | 0.07% | 00.0% | Unchanged |
| Principal Financial Group Inc | 406,102 | $3.23M | 0.00% | +100,856+33.0% | Added |
| American Century Companies Inc | 451,827 | $3.59M | 0.00% | +30,530+7.2% | Added |
| BlackRock Inc. | 466,804 | $3.71M | 0.00% | +162,575+53.4% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 500,000 | $3.98M | 0.09% | 00.0% | Unchanged |
| Walleye Capital LLC | 888,700 | $7.07M | 0.20% | +640,346+257.8% | Added |
| Vantage Consulting Group Inc | 1,186,215 | $9.43M | 5.29% | −493,934−29.4% | Reduced |
| Pictet Asset Management SA | 1,295,018 | $10.3M | 0.01% | 00.0% | Unchanged |
| GCM Grosvenor Holdings, LLC | 1,298,012 | $10.3M | 2.33% | +1,298,012 | New |
| Eventide Asset Management, LLC | 1,879,959 | $14.9M | 0.32% | −95,041−4.8% | Reduced |
| Price T Rowe Associates Inc | 1,961,210 | $15.6M | 0.00% | −501,426−20.4% | Reduced |
| Alliancebernstein L.P. | 2,961,624 | $23.5M | 0.01% | +4,568+0.2% | Added |
| JPMorgan Chase & Co | 3,453,672 | $27.5M | 0.00% | +39,042+1.1% | Added |
| Redmile Group, LLC | 7,512,029 | $59.7M | 2.28% | +79,600+1.1% | Added |
| FMR LLC | 7,681,046 | $61.1M | 0.01% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −19,193−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −5,921−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −2,882−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −950−100.0% | Sold out |
| Grosvenor Holdings, L.L.C. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |